Interestingly, if naïve to treatment patients are excluded from the comparison between ACPA+ and ACPA− RA, ACPA+ patients maintain a significantly (* p = 0.03) higher Tfh cell population (Figure 3E). Here, PRTN3 is linked to rheumatoid arthritis.